243 related articles for article (PubMed ID: 23474121)
1. First structure of protein kinase CK2 catalytic subunit with an effective CK2β-competitive ligand.
Raaf J; Guerra B; Neundorf I; Bopp B; Issinger OG; Jose J; Pietsch M; Niefind K
ACS Chem Biol; 2013 May; 8(5):901-7. PubMed ID: 23474121
[TBL] [Abstract][Full Text] [Related]
2. Interaction between CK2α and CK2β, the subunits of protein kinase CK2: thermodynamic contributions of key residues on the CK2α surface.
Raaf J; Bischoff N; Klopffleisch K; Brunstein E; Olsen BB; Vilk G; Litchfield DW; Issinger OG; Niefind K
Biochemistry; 2011 Feb; 50(4):512-22. PubMed ID: 21142136
[TBL] [Abstract][Full Text] [Related]
3. The interaction of CK2alpha and CK2beta, the subunits of protein kinase CK2, requires CK2beta in a preformed conformation and is enthalpically driven.
Raaf J; Brunstein E; Issinger OG; Niefind K
Protein Sci; 2008 Dec; 17(12):2180-6. PubMed ID: 18824508
[TBL] [Abstract][Full Text] [Related]
4. Structure of the human protein kinase CK2 catalytic subunit CK2α' and interaction thermodynamics with the regulatory subunit CK2β.
Bischoff N; Olsen B; Raaf J; Bretner M; Issinger OG; Niefind K
J Mol Biol; 2011 Mar; 407(1):1-12. PubMed ID: 21241709
[TBL] [Abstract][Full Text] [Related]
5. First inactive conformation of CK2 alpha, the catalytic subunit of protein kinase CK2.
Raaf J; Issinger OG; Niefind K
J Mol Biol; 2009 Mar; 386(5):1212-21. PubMed ID: 19361447
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of a C-terminal deletion mutant of human protein kinase CK2 catalytic subunit.
Ermakova I; Boldyreff B; Issinger OG; Niefind K
J Mol Biol; 2003 Jul; 330(5):925-34. PubMed ID: 12860116
[TBL] [Abstract][Full Text] [Related]
7. Unexpected CK2β-antagonistic functionality of bisubstrate inhibitors targeting protein kinase CK2.
Pietsch M; Viht K; Schnitzler A; Ekambaram R; Steinkrüger M; Enkvist E; Nienberg C; Nickelsen A; Lauwers M; Jose J; Uri A; Niefind K
Bioorg Chem; 2020 Mar; 96():103608. PubMed ID: 32058103
[TBL] [Abstract][Full Text] [Related]
8. Primary and secondary interactions between CK2alpha and CK2beta lead to ring-like structures in the crystals of the CK2 holoenzyme.
Niefind K; Issinger OG
Mol Cell Biochem; 2005 Jun; 274(1-2):3-14. PubMed ID: 16335523
[TBL] [Abstract][Full Text] [Related]
9. The protein kinase CK2(Andante) holoenzyme structure supports proposed models of autoregulation and trans-autophosphorylation.
Schnitzler A; Olsen BB; Issinger OG; Niefind K
J Mol Biol; 2014 May; 426(9):1871-82. PubMed ID: 24594356
[TBL] [Abstract][Full Text] [Related]
10. Development of a high-throughput screening-compatible assay to identify inhibitors of the CK2α/CK2β interaction.
Hochscherf J; Lindenblatt D; Steinkrüger M; Yoo E; Ulucan Ö; Herzig S; Issinger OG; Helms V; Götz C; Neundorf I; Niefind K; Pietsch M
Anal Biochem; 2015 Jan; 468():4-14. PubMed ID: 25233003
[TBL] [Abstract][Full Text] [Related]
11. Structure-based design of small peptide inhibitors of protein kinase CK2 subunit interaction.
Laudet B; Barette C; Dulery V; Renaudet O; Dumy P; Metz A; Prudent R; Deshiere A; Dideberg O; Filhol O; Cochet C
Biochem J; 2007 Dec; 408(3):363-73. PubMed ID: 17714077
[TBL] [Abstract][Full Text] [Related]
12. Role of plant-specific N-terminal domain of maize CK2β1 subunit in CK2β functions and holoenzyme regulation.
Riera M; Irar S; Vélez-Bermúdez IC; Carretero-Paulet L; Lumbreras V; Pagès M
PLoS One; 2011; 6(7):e21909. PubMed ID: 21789193
[TBL] [Abstract][Full Text] [Related]
13. The catalytic subunit of human protein kinase CK2 structurally deviates from its maize homologue in complex with the nucleotide competitive inhibitor emodin.
Raaf J; Klopffleisch K; Issinger OG; Niefind K
J Mol Biol; 2008 Mar; 377(1):1-8. PubMed ID: 18242640
[TBL] [Abstract][Full Text] [Related]
14. CK2beta interacts with and regulates p21-activated kinases in Drosophila.
Mentzel B; Jauch E; Raabe T
Biochem Biophys Res Commun; 2009 Feb; 379(2):637-42. PubMed ID: 19121626
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase CK2 in health and disease: Protein kinase CK2: from structures to insights.
Niefind K; Raaf J; Issinger OG
Cell Mol Life Sci; 2009 Jun; 66(11-12):1800-16. PubMed ID: 19387553
[TBL] [Abstract][Full Text] [Related]
16. Structure-based Discovery of Novel CK2α-Binding Cyclic Peptides with Anti-cancer Activity.
Tang S; Zhang N; Zhou Y; Cortopassi WA; Jacobson MP; Zhao LJ; Zhong RG
Mol Inform; 2019 Mar; 38(3):e1800089. PubMed ID: 30307134
[TBL] [Abstract][Full Text] [Related]
17. Design of CK2β-Mimicking Peptides as Tools To Study the CK2α/CK2β Interaction in Cancer Cells.
Lindenblatt D; Horn M; Götz C; Niefind K; Neundorf I; Pietsch M
ChemMedChem; 2019 Apr; 14(8):833-841. PubMed ID: 30786177
[TBL] [Abstract][Full Text] [Related]
18. Toward selective CK2alpha and CK2alpha' inhibitors: Development of a novel whole-cell kinase assay by Autodisplay of catalytic CK2alpha'.
Bollacke A; Nienberg C; Borgne ML; Jose J
J Pharm Biomed Anal; 2016 Mar; 121():253-260. PubMed ID: 26786382
[TBL] [Abstract][Full Text] [Related]
19. Differential localization of alpha' and beta subunits of protein kinase CK2 during rat spermatogenesis.
Alvarado-Díaz CP; Tapia JC; Antonelli M; Moreno RD
Cell Tissue Res; 2009 Oct; 338(1):139-49. PubMed ID: 19711102
[TBL] [Abstract][Full Text] [Related]
20. The multiple personalities of the regulatory subunit of protein kinase CK2: CK2 dependent and CK2 independent roles reveal a secret identity for CK2beta.
Bibby AC; Litchfield DW
Int J Biol Sci; 2005; 1(2):67-79. PubMed ID: 15951851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
